SODIUM NITROPRUSSIDE
- Product NDC
- 69097-532
- 11-digit product format
- 690970532
- Labeler code
- 69097
- Product ID
- 69097-532_5dd9b567-3a8b-4cf1-a2cd-9197b04f42a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM NITROPRUSSIDE
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA210855
- Marketing category
- ANDA
- Marketing start
- 2018-07-16
- Marketing end
- 0000-00-00
- Substance
- SODIUM NITROPRUSSIDE
- Active strength
- 50 mg/2mL
- Pharmacologic classes
- Vasodilation [PE],Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-532 | SODIUM NITROPRUSSIDE INJECTION, SOLUTION, CONCENTRATE [CIPLA USA INC.] | 2 | Legacy NDC | 20181206_893129d0-a150-4c4e-83fc-c030f462cae1.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-532-32 | 69097053232 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-532-32) > 2 mL in 1 VIAL, SINGLE-DOSE | 2018-07-16 | 0000-00-00 | No | No | Current |